[Asia Economy Reporter Kum Boryeong] Cha Biotech announced on the 8th that it has acquired a patent related to 'Stem Cell-Derived Skin Progenitor Cell Culture Medium and Its Manufacturing Method.'



Cha Biotech stated, "With the safe and optimized culture medium produced through this invention, we plan to utilize it as a raw material for various products that can improve skin tissue damage such as anti-aging, burns, and stretch marks, aiming to enter overseas markets," and added, "We also plan to apply it in the development of pharmaceuticals such as exosome therapies based on the culture medium."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing